EUCTR2008-000714-74-SE进行中（未招募）不适用
Premedication in paediatric patients: Dose finding study of clonidine administrated as nasal aerosol.
Institution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin0 个研究点开始时间: 2008年2月14日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.ASA class I and II patients
- •2.Patients between the age of 6 months and 6 years with a weight between 10 and 25 kilogram.
- •3.Planned for a surgical procedure at Astrid Lindgrens Childrens Hospital which require generell anaesthesia
- •4.Oral and written consent from the patient/parent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Known allergy to clonidine
- •2.Impaired development/mental handicap which makes grading of sedation impossible
- •3.Language diffuculties requiring information by interpreter
研究者
相似试验
进行中（未招募）
1 期
Traitement précoce de patients pédiatriques présentant un syndrome hémolytique et urémique typique par l’anticorps monoclonal anti-C5 eculizumab : essai thérapeutique prospectif randomisé contrôlé contre placebo de phase IIIHemolytic and uremic syndromeMedDRA version: 17.0 Level: LLT Classification code 10042814 Term: Syndrome hemolytic uremic System Organ Class: 100000004851EUCTR2014-001169-28-FRCentre Hospitalier de Toulouse100
进行中（未招募）
1 期
Preanesthetic medication in pediatric patients: A comparison of midazolam, clonidine and dexmedetomidineIs there a difference in anxiety- and sedation-level, and in anesthesia induction compliance between the preanesthetics included in study, in pediatric patients? Can we prevent and reduce anxiety without causing negative cardiorespiratory effects by selected preanesthetic included in study, in TIVA in pediatric patients? Does the preanesthetic used in this study prevent and/or reduce pain, vomiting, shivering, events of emergence delirium and maladaptive behaviors, without prolonging recovery?EUCTR2015-003676-70-SEorrbottens läns landsting
进行中（未招募）
1 期
A PAEDIATRIC PHASE I/II STUDY OF INTERMITTENT DOSING OF THE MEK-1 INHIBITOR SELUMETINIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND INOPERABLE PLEXIFORM NEUROFIBROMA AND/OR PROGRESSIVE OPTIC PATHWAY GLIOMANeurofibromatosis type 1 associated plexiform neurofibromas Neurofibromatosis type 1 associated progressive or relapsed optic pathway gliomaMedDRA version: 20.0 Level: LLT Classification code 10029270 Term: Neurofibromatosis, type 1 (von Recklinghausen's disease) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10065866 Term: Plexiform neurofibroma System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10030935 Term: Optic nerve glioma System Organ Class: 100000004864EUCTR2017-002635-41-GBGreat Ormond Street Hospital38
已完成
不适用
Prediction of medication response in children with ADHD: EEG differences between responders and non-responders to methylphenidate.ADHD, methylphenidate response, EEG, DNA, CANTAB, spatial span, spatial working memory, stop-task, CPT, theta/beta ratioNL-OMON26488trecht Institute for Pharmaceutical Sciences, Utrecht University50
已完成
不适用
Prediction of medication response in children with Attention Deficit Hyperactivity Disorder (ADHD): Electroencephalogram (EEG) differences between responders and non-responders to methylphenidateMedication response in children with Attention Deficit Hyperactivity Disorder (ADHD)Mental and Behavioural DisordersHyperkinetic disordersISRCTN32841168trecht Institute for Pharmaceutical Sciences (The Netherlands)50